My watch list
my.bionity.com  
Login  

Confo Therapeutics enters into drug discovery collaboration with Roche

21-Dec-2017

Confo Therapeutics, announced that it has entered into a research collaboration and license agreement with Roche for the discovery, development and commercialisation of novel, small molecule agonists of an undisclosed G-protein coupled receptor (GPCR) for the treatment of neurological and developmental disorders.

Under the terms of the agreement, Roche gains exclusive rights to the compounds resulting from the collaboration and will be responsible for their development, manufacturing and commercialisation. The financial terms include an upfront payment, pre-clinical milestones and research funding to Confo Therapeutics totaling €6 million over the initial 30 months period of the collaboration. In addition, Confo Therapeutics is eligible to receive up to €81.5 million of payments for certain development, regulatory and commercial milestones, plus tiered royalties on the annual net sales of any products resulting from the collaboration.

“Securing this partnership with Roche is another significant corporate milestone for Confo Therapeutics,” said Dr. Cedric Ververken, CEO. “The decision by a global pharmaceutical company to work with Confo Therapeutics further validates the strength of our proprietary Confo technology and the capabilities of our team. It also strengthens our resolve to vigorously pursue our own proprietary product pipeline in addition to enabling our partners to develop valuable medicines for patients.”

Facts, background information, dossiers
  • Cedric Ververken
  • drug discovery coll…
  • collaborations
More about Confo Therapeutics
More about Roche
  • News

    Recipharm signs manufacturing agreement and acquires facility in Spain

    Recipharm AB announces that it has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose products. Recipharm will also acquire a manufacturing facility currently employing approximately 200 people locate ... more

    Merck expands distribution agreement with Roche

    Merck announced an expansion of its distribution alliance with Roche to include the polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) enzyme products of Kapa Biosystems, a company acquired by Roche in 2015. The addition of the Kapa portfolio strengthens Merck’s existing ... more

    LDC and Roche will jointly advance innovative drug discovery projects

    The Lead Discovery Center GmbH (LDC) and Roche will collaborate to identify and leverage innovative therapeutic opportunities that address diseases of unmet medical need across several disease areas. Projects will be sourced from the LDC’s academic partners, as well as from Roche’s innovati ... more

  • Companies

    Roche Deutschland Holding GmbH

    more

    Roche Austria GmbH

    Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche i ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE